The Department of Pathology and Anatomical Sciences participates weekly on activities and teleconferences that provide continuing medical education to faculty members and residents. These include, but are not limited to, audio teleconferences held by the American Society of Clinical Pathologists (ASCP), College of American Pathologists (CAP), and monthly conference series held within the department.
The CME approved conference series for the department include: Didactic Conference, Journal Club, Current Topics in Transfusion Medicine & Clinical Pathology, Autopsies, and Chemistry Lectures. Below you will find a short description of the educational objectives for each of the conference series. These conferences consist of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a pathologist uses to provide services for patients, the public, or the profession. The content of our conferences is the body of knowledge and skills generally recognized and accepted by pathologist as within the basic medical sciences, the discipline of clinical medicine, and the provision of health care for our clinical services.
Objectives of this lecture series are to provide CME in anatomic and clinical pathology. Faculty present updates in cytology, dermatopathology, endocrinology, neuropathology, surgical pathology, problem cases on frozen sections, renal pathology, hematopathology and molecular diagnosis. There are also monthly case-study conferences, dissections, and updates with literature review.
Topics are determined prior to each conference and all interested attendees are given a copy of the journal articles to be discussed. A full discussion occurs at a scheduled time, with residents and faculty having deep integrated discussions.
Current Topics in Transfusion Medicine & Clinical Pathology
Faculty present updates in endocrinology, blood banking, transfusion, hematopathology and molecular diagnosis. There are also monthly case-study conferences, dissections, and updates with literature review.
Dr. Christopher Stacy is the director of the Autopsy Series at MU & the VA. He is also the deputy medical examiner for Boone, Callaway & Greene Counties. He coordinates post-mortem review and forensic pathology updates and interest groups. This occurs 3-5 hours per month. The objective is to update physicians on the most current trends and testing in evaluation of manner, mechanism, and cause of death.
Objectives in clinical chemistry are identified by Dr. Ritter in consulting with other faculty and residents. Dr. Ritter provides a clinical chemistry didactic conference. These are supplemented by purchased CME audio teleconferences with the ASCP and CAP. Diagnostics, laboratory issues are discussed.
Please note: The faculty of the Department of Pathology and Anatomical Sciences have no relationships with any commercial firms having products related to topics discussed at these conferences. Therefore there are no conflicts that will interfere with the proper accreditation for these series.
The Office of Continuing Education, School of Medicine, University of Missouri is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Office of Continuing Education, School of Medicine, University of Missouri designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The following guidelines are required by the ACCME and FDA regarding content of CME presentations:
- Representatives of industry may not determine the content of a speaker’s presentation. Handouts and AV material may not include promotional material for any drug or medical device.
- The program taken as a whole must give a balanced view of therapeutic options. Even if one particular approach is advocated, alternatives must be discussed fairly.
- Speakers should clearly indicate when they are stating personal opinion or clinical impressions rather than research-based conclusions. When presenting research-based conclusions, the studies must be discussed or at least referenced in handouts.
- When discussing unlabeled or investigational uses of a drug or medical device, these uses must be clearly identified as such. This holds true for handouts as well as presentations and discussions.
- Generic names for drugs and devices should be used in handouts and discussion. In cases where a brand name is better known than the generic, the speaker may alleviate this problem by a brief explanation of the product’s generic name, followed by use of the generic name in the remainder of the presentation or handout.